Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Immune Thrombocytopenia”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02402998
What this trial is testing

Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia

Who this might be right for
Primacy Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 55
Post-approval studies (Phase 4)Study completedNCT02556814
What this trial is testing

Caffeic Acid Combining High-dose Dexamethasone in Management of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 214
Large-scale testing (Phase 3)Study completedNCT02334813
What this trial is testing

Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
University Hospital, Essen 26
Large-scale testing (Phase 3)Study completedNCT05369208
What this trial is testing

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 19
Testing effectiveness (Phase 2)Study completedNCT04669600
What this trial is testing

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)
Bioverativ, a Sanofi company 12
Post-approval studies (Phase 4)UnknownNCT05861297
What this trial is testing

Immune Thrombocytopenia Management in Adults

Who this might be right for
Immune Thrombocytopenia Purpura
Nahda University 467
Testing effectiveness (Phase 2)UnknownNCT02338414
What this trial is testing

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Samsung Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT02401061
What this trial is testing

PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT06287567
What this trial is testing

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 17
Early research (Phase 1)Looking for participantsNCT06880081
What this trial is testing

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Chongqing Peg-Bio Biopharm Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT00621894
What this trial is testing

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Who this might be right for
Immune Thrombocytopenic Purpura
GlaxoSmithKline 23
Testing effectiveness (Phase 2)Study completedNCT04812483
What this trial is testing

Immunomodulation With Eltrombopag in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
University Children's Hospital Basel 2
Testing effectiveness (Phase 2)Study completedNCT03395210
What this trial is testing

Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 86
Large-scale testing (Phase 3)UnknownNCT06004856
What this trial is testing

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd. 195
Testing effectiveness (Phase 2)Ended earlyNCT01129024
What this trial is testing

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shionogi 19
Early research (Phase 1)Study completedNCT02281370
What this trial is testing

Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
GlaxoSmithKline 39
Post-approval studies (Phase 4)Study completedNCT01356511
What this trial is testing

High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Shandong University 261
Large-scale testing (Phase 3)Study completedNCT00370331
What this trial is testing

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 197
Testing effectiveness (Phase 2)Ended earlyNCT00225875
What this trial is testing

Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy

Who this might be right for
Autoimmune Thrombocytopenic Purpura
Assistance Publique - Hôpitaux de Paris 65
Testing effectiveness (Phase 2)Study completedNCT00372892
What this trial is testing

Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Hamilton Health Sciences Corporation 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation